Filing Details
Century Therapeutics, Inc. (NASDAQ:IPSC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:IPSC
Century Therapeutics, Inc. (IPSC) Files Quarterly Report for Q0
Century Therapeutics, Inc. (NASDAQ:IPSC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
At publication ·
What changed
Century Therapeutics, Inc. (NASDAQ:IPSC) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Century Therapeutics, Inc. (NASDAQ: IPSC) filed its quarterly report (Form 10-Q) with the SEC on August 12, 2026.
- The company's stock trades at $1.96 per share with a market capitalization of $50.9 million.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance, though the article does not specify Q0 revenue figures or other financial metrics.
Market Context
Century Therapeutics, Inc.'s stock currently trades at $1.96 with a market capitalization of $50.9M.
The 10-Q provides Century Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Century Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IPSC Stock Page
Frequently Asked Questions
Where can I read IPSC's SEC filings?
Browse all filings on our IPSC SEC filings page.
What types of SEC filings does Century Therapeutics, Inc. file?
Public companies like Century Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.